GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (FRA:YB3) » Definitions » Other Operating Expense

Shin Nippon Biomedical Laboratories (FRA:YB3) Other Operating Expense : €64.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories Other Operating Expense?

Shin Nippon Biomedical Laboratories's Other Operating Expense for the three months ended in Dec. 2023 was €19.1 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €64.0 Mil.

Shin Nippon Biomedical Laboratories's quarterly Other Operating Expense increased from Jun. 2023 (€12.8 Mil) to Sep. 2023 (€12.9 Mil) and increased from Sep. 2023 (€12.9 Mil) to Dec. 2023 (€19.1 Mil).

Shin Nippon Biomedical Laboratories's annual Other Operating Expense increased from Mar. 2022 (€31.1 Mil) to Mar. 2023 (€40.3 Mil) but then declined from Mar. 2023 (€40.3 Mil) to Mar. 2024 (€39.6 Mil).


Shin Nippon Biomedical Laboratories Other Operating Expense Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shin Nippon Biomedical Laboratories Other Operating Expense Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.69 29.35 31.14 40.32 39.59

Shin Nippon Biomedical Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.53 12.84 12.91 19.09 19.15

Shin Nippon Biomedical Laboratories Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €64.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shin Nippon Biomedical Laboratories Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Shin Nippon Biomedical Laboratories (FRA:YB3) Business Description

Traded in Other Exchanges
Address
8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (FRA:YB3) Headlines

No Headlines